I think I've read everything available on QIDP and the FDA approvals process. I've also compared timelines from other recent approvals of QIDP drugs. So I'm genuinely baffled by the 12 month for phase 1 trials.
- Forums
- ASX - By Stock
- RCE
- Ann: Update on Progress of Broad Spectrum Antibiotic RECCE 327
Ann: Update on Progress of Broad Spectrum Antibiotic RECCE 327, page-5
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $115.9M |
Open | High | Low | Value | Volume |
50.0¢ | 52.0¢ | 49.0¢ | $164.9K | 323.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28482 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.0¢ | 27141 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15353 | 0.485 |
1 | 1042 | 0.480 |
2 | 59071 | 0.475 |
2 | 111000 | 0.470 |
1 | 9622 | 0.465 |
Price($) | Vol. | No. |
---|---|---|
0.515 | 20000 | 1 |
0.525 | 55716 | 2 |
0.540 | 6758 | 1 |
0.550 | 23920 | 3 |
0.560 | 40000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online